Results 131 to 140 of about 36,099,759 (329)

HOW TO EVALUATE SCIENTIFIC PRODUCTION

Revista do Colégio Brasileiro de Cirurgiões
Objective: To conduct a critical analysis of the two main bibliometric indexes used by science: the impact factor and the H index. Method: Research was conducted on PubMed using the keywords: impact factor, Bibliometrics and H index.
Alberto Azoubel Antunes
doaj   +1 more source

Discussion: “Orifice-Metering Coefficients and Pipe Friction Factors for the Turbulent Flow of Lead-Bismuth Eutectic” (Johnson, H. A., Hartnett, J. P., Clabaugh, W. J., and Fried, L., 1957, Trans. ASME, 79, pp. 1079–1083) [PDF]

, 1957
O.E. Dwyer
openalex   +1 more source

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

Molecular Oncology, EarlyView.
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Elin Borgen, Cecilie Bendigtsen Schirmer, Bjørnar Gilje, Øystein Garred, Jon Lømo, Marius Stensland, Oddmund Nordgård, Ragnhild Sørum Falk, Randi R. Mathiesen, Hege G. Russnes, Jon Amund Kyte, Bjørn Naume   +13 more
wiley   +1 more source

Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration

Science, 2005
J. Haines, M. Hauser, S. Schmidt, W. Scott, L. Olson, P. Gallins, Kylee L. Spencer, S. Y. Kwan, M. Noureddine, J. Gilbert, N. Schnetz-Boutaud, A. Agarwal, E. Postel, M. Pericak-Vance   +13 more
semanticscholar   +1 more source

Human complement factor H [PDF]

, 1987
Dierich, Manfred P., Linke, Reinhold P., Schulz, T. F., Schwaeble, Wilhelm, Weiss, Elisabeth H., Zwirner, Jörg   +5 more
core   +1 more source

Absolute Convergence Factors for H^p Series [PDF]

, 1969
James Caveny
openalex   +1 more source

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini, Ezgi Oner, Mark P. Ward, Sinead Hurley, Brian David Henderson, Faye Lewis, Stephen P. Finn, Gerard J. Fitzmaurice, John J. O'Leary, Sharon O'Toole, Lorraine O'Driscoll, Kathy Gately   +11 more
wiley   +1 more source

Measurement and Analysis of Thermal Disadvantage Factor for UO₂-H₂O Lattices [PDF]

, 1966
Setsuo KOBAYASHI
openalex   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

Molecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi, Janelle‐Cheri Millen, Romela Irene Ramos, Jennifer A. Linehan, Timothy G. Wilson, Dave S. B. Hoon, Matias A. Bustos   +6 more
wiley   +1 more source

Discussion: “Empirical Correlation of Factors Influencing Departure From Nucleate Boiling in Steam-Water Mixtures Flowing in Vertical Round Tubes” (Pasint, D., and Pai, R. H., 1966, ASME J. Heat Transfer, 88, pp. 367–373) [PDF]

, 1966
B.W. LeTourneau, S. J. Green
openalex   +1 more source